Paul Andrew Moore - 18 Jul 2022 Form 3 Insider Report for Zymeworks Inc. (ZYME)

Role: Chief Scientific Officer
Signature: /s/ Daniel Dex, Attorney-in-Fact
Issuer symbol: ZYME
Transactions as of: 18 Jul 2022
Net transactions value: $0
Form type: 3
Filing time: 19 Jul 2022, 21:00:11 UTC
Next filing: 06 Jan 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney